Key Events This Week
27 Apr: Upper circuit hit at Rs.443.65 (+9.99%)
28 Apr: Minor correction to Rs.443.15 (-0.14%)
29 Apr: Modest recovery to Rs.445.15 (+0.45%)
30 Apr: Slight dip to Rs.443.55 (-0.36%)
May 06
BSE+NSE Vol: 4.76 lacs

Blue Jet Healthcare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from expensive to very expensive territory. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now stand well above historical and peer averages, prompting a downgrade in its Mojo Grade from Hold to Sell as of 6 January 2026.
Read full news article
Blue Jet Healthcare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. This change comes alongside a significant 7.39% gain in a single day, reflecting renewed investor interest despite lingering challenges in its longer-term performance.
Read full news article
The Sensex advanced 0.98% on 4 May 2026, yet Blue Jet Healthcare Ltd outpaced the broader market with a 7.29% gain, touching an intraday high of Rs 476. This 5.88 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
27 Apr: Upper circuit hit at Rs.443.65 (+9.99%)
28 Apr: Minor correction to Rs.443.15 (-0.14%)
29 Apr: Modest recovery to Rs.445.15 (+0.45%)
30 Apr: Slight dip to Rs.443.55 (-0.36%)

Blue Jet Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read full news article
At Rs 443.65, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Blue Jet Healthcare Ltd locked at its upper circuit of 9.99% on 27 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
The Sensex advanced 0.66% on 27 Apr 2026, yet Blue Jet Healthcare Ltd outpaced the broader market with a robust 7.84% gain, reaching an intraday peak of Rs 418.95. This 2.77 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news article
Blue Jet Healthcare Ltd is rated Sell by MarketsMOJO. This rating was last updated on 6 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 16 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article